Midodrine Hydrochloride
Sponsors
Shire, James J. Peters Veterans Affairs Medical Center, Dr. Bob Sheldon, University of Virginia, Bürgerspital Solothurn
Conditions
Autonomic DysreflexiaAutonomic IntegrityBaroreceptor IntegrityBlood PressureCerebral Blood FlowCognitive FunctionHypotensionHypotension, Orthostatic
Phase 2
A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
CompletedNCT00426842
Start: 2007-01-31End: 2011-03-31Updated: 2016-10-10
The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury
CompletedNCT02893553
Start: 2016-12-31End: 2021-12-31Updated: 2024-10-01
Treatment of Post-SCI Hypotension
CompletedNCT02919917
Start: 2017-06-01End: 2021-09-01Updated: 2025-02-21
Phase 3
Phase 4
A Study for Patients With Neurogenic Orthostatic Hypotension
CompletedNCT00046475
Start: 1997-12-01End: 1999-11-24Updated: 2021-06-11
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
CompletedNCT00555880
Start: 2004-09-08End: 2005-03-21Updated: 2021-06-14
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV
Active, not recruitingNCT01456481
Start: 2011-11-30End: 2024-12-31Updated: 2024-05-09
Body Temperature in Persons With Tetraplegia When Exposed to Cold
CompletedNCT01822535
Start: 2011-07-31End: 2015-10-31Updated: 2016-03-04
Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia
CompletedNCT02379156
Start: 2015-04-30End: 2022-12-31Updated: 2025-03-21
RaGuS Trial by Postoperative Patients
NCT04440085
Start: 2020-09-14End: 2021-09-14Target: 50Updated: 2020-06-19
Treatment of Orthostatic Hypotension in SCI
RecruitingNCT05839652
Start: 2023-07-01End: 2026-06-30Target: 25Updated: 2024-10-01